摘要
Johannes Flores DAYRIT 医师
皮肤科医师
Facial dyschromias: Differential diagnosis and treatment
Objectives: The objective of the study is to describe the clinical, histopathologic, and dermoscopy findings of exogenous ochronosis in 10 cases, and iatrogenic dyschromia in 6 cases. Differential diagnosis and treatment will also be discussed.
Introduction: Facial dyschromias are common in skin of color and may result as complications of long term use of skin lightening products. The clinical manifestations have not been meticulously defined and consensus on proper treatment has not yet been established. Exogenous ochronosis is a paradoxical hyperpigmentation observed in patients who self-medicated with topical hydroquinone for the treatment of melasma. Iatrogenic dyschromia refers to alteration in skin color induced by medical treatment or pigment lasers. These conditions may look similar to other forms of dyschromia and dyspigmentation.
Materials / method: Case series of exogenous ochronosis (18 cases) and iatrogenic dyschromia (6 cases) seen at the Research Institute for Tropical Medicine from March 2007 to December 2024.
Results: Patients with ochronosis showed grayish black hyperpigmentation more prominent on the zygomatic areas. Dermoscopy revealed reddish brown clods and serpentine blood vessels. Iatrogenic dyschromia present with mottled brown and hypopigmented/depigmented patches. Histopathology of both conditions present with altered collagen and solar elastosis indicating moderate to severe dermal damage.
Conclusion: The clinical , dermoscopic, and histological features of exogenous ochronosis and iatrogenic dyschromias show distinct features. Patients were advised to discontinue all skin lightening skin care products. Severe cases were advised laser resurfacing and collagen remodelling treatments. The treatments showed variable improvement in pigmentation.
披露 - Johannes Flores DAYRIT
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2025年 7月 25日 - Recorded during IMCAS Asia 2025